As shown in Figure 1, Supplementary Figure 1 and Supplementary Figure 2, before pretreatment (on day −11), the levels of IL-10, TP and LIGHT in the sera of aGVHD patients were significantly different from those in the sera of the non-GVHD group (p < 0.05). The gene discussed is IL10; the disease is graft versus host disease.